Dear Subscriber
Journal of Advanced Biotechnology and Experimental Therapeutics (JABET) is an open-access, international, peer-reviewed scientific journal publishing all aspects of biotechnology and experimental therapeutics. It provides a platform for academicians all over the world to share various new issues on recent discoveries in the biotechnology and biomedical sciences.
●Indexing: Scopus, DOAJ, CNKI, CABI abstract, and many more!
●Article types: Original article, Review article, Short communication, Editorial, and Commentary.
●Acceptance rate: 11%
●Submission to the final decision: 36 days
●Acceptance to publication: 7 days
Your impactful research is poised to drive significant advancements in the biotechnology and biomedical sciences, and we would be privileged to share your future findings with our readership. Note: A special discount is available.
Best regards,
Editorial Office
Journal of Advanced Biotechnology and Experimental Therapeutics
Seoul, South Korea
Email: jabet.editor@bsmiab.org and jabet.editor@gmail.com
Website | Twitter | LinkedIn |
